PATENT CLAIM ANALYSIS

Application Number: 15986316
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-11
Patent Classification: ["514", "762000"]

Abstract:
Provided herein are pharmaceutical compositions that comprise myrcene, optionally in admixture with cannabinoids and other terpenes, typically substantially free of THC and THCA, for targeting TRPV1 receptors. Also provided are methods of using the pharmaceutical compositions to desensitize TRPV1 receptors in order to treat pain, cardiovascular diseases such as cardiac hypertrophy, overactive bladder, and chronic cough.

Claim (Index 73):
The method of  claim 71 , wherein the pharmaceutical composition is administered at a dose, by a route of administration, and on a schedule sufficient to maintain effective levels of myrcene at the nociceptors for at least 7 days.

Metadata:
- Claim Count in Document: 234.0
- Percentile: 93.0
- Lexical Diversity: 1.33333
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15729565', '15889112', '15152253', '14742503', '15588505']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7981574833419446
- 35 USC 102 Novelty (BERT): 0.5454855397262515
- Combined Prediction Score: 0.7728902889803753
- Mean Citation Score: 334.5427880000001
- Max Citation Score: 446.3893
- Similarity Product: 226.9707510071397

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test